Artemis Acquisition, a blank check company targeting healthcare in the US and Europe, filed on Wednesday with the SEC to raise up to $200 million in an initial public offering.
The Salem, SC-based company plans to raise $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. At the proposed deal size, Artemis Acquisition would command a market value of $250 million.
The company is led by CEO and Chairman Steve Wiggins, whose past roles include founder and Chairman of Remedy Partners, founder and member of Centerstone Partners, and founder and CEO of HealthMarket and Oxford Health Plans. The company plans to target the healthcare or healthcare related industries in the US and Europe.
Artemis Acquisition was founded in 2021 and plans to list on the Nasdaq under the symbol ARACU. The company filed confidentially on July 9, 2021. Cantor Fitzgerald is the sole bookrunner on the deal.
